Ranks distinct AI gain and problem claims from the published record. Scores reward impact, independent source strength, scale, confidence, and recency.
Researchers used network toxicology, multi-model machine learning, molecular docking, and in vitro experiments in human intestinal epithelial cells to probe the tire-derived pollutant 6PPD-quinone. The workflow identified 60 overlapping 6PPD-Q-IBD targets and prioritized six core genes, with NR1H4 as a key mediator that binds strongly to 6PPD-Q.
By September 2026, researchers surveyed 73 Canadian medical students to test whether perceptions of radiology's procedural scope and AI integration differed by interest in radiology. Interested students rated therapeutic and diagnostic procedures as more important and reported higher perceived career sustainability, while non-interested students reported higher perceived AI impact.
On September 4, 2026, a peer-reviewed study in Academic Radiology evaluated 25 musculoskeletal imaging cases where three AI systems generated visual summaries from report text alone. Two fellowship-trained MSK radiologists rated each image for anatomical accuracy and clinical usefulness, finding Gemini 3.0 Pro most consistent at 40-42% accurate and 60-65% useful, while ChatGPT and Perplexity frequently produced plausible but inaccurate images.
A September 2026 review in The Lancet Digital Health summarizes how digital pathology, image analysis, and AI, including deep learning on high-resolution whole-slide images, are being applied to liver disease, liver cancer diagnosis, and transplantation assessment. The authors describe expanding use from long-standing research applications to increasing clinical practice access.
On August 5, 2026, a peer-reviewed study in JCO Oncology Practice evaluated AI translation of three oncology clinical trial informed consent forms from English to Spanish, comparing DeepL Pro, ChatGPT-4o, and a medically trained model Med_English2Spanish against certified translations using five equivalence domains scored by two bilingual physicians.
On August 5, 2026, a viewpoint in the Journal of Participatory Medicine described how large language model chatbots and purpose-built companion agents are being used by millions for emotional support, distress processing, and relationship-like interaction, with 48.7% of people with self-reported mental health concerns reporting use for mental health support.
On 2026-08-04, a peer-reviewed cross-sectional study reported testing ChatGPT4, Gemini 2.0, Copilot, DeepSeek V3, and Grok 3 on 12 tracheostomy care questions, with three blinded laryngologists rating responses for accuracy, completeness, clarity, and sourcing, and readability measured with nine metrics.
A cross-sectional study tested four AI chatbots on 97 anonymized CBCT cases of jaw lesions, comparing performance on reconstructed 2D panoramic views and, for Manus, raw 3D DICOM data. Reports were scored for accuracy, relevance and feasibility, revealing statistically significant differences between systems.